Teva Pharmaceutical Industries Ltd. ADR (TEVA) Social Stream
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Price Targets From Analysts
Use the tables below to see what analysts covering TEVA PHARMACEUTICAL INDUSTRIES LTD think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-30 | 10 | $11 | $10 | $10.5 | $10.88 | -3.49% |
| 2022-02-07 | 11 | $11 | $10 | $10.5 | $10.88 | -3.49% |
| 2022-02-10 | 11 | $11 | $9 | $10.375 | $10.88 | -4.64% |
| 2022-03-25 | 12 | $11 | $9 | $10.444 | $10.88 | -4.01% |
| 2022-04-05 | 12 | $13 | $9 | $10.666 | $10.88 | -1.97% |
| 2022-04-28 | 12 | $13 | $10 | $10.777 | $10.88 | -0.95% |
| 2022-05-04 | 12 | $13 | $10 | $10.75 | $10.88 | -1.19% |
| 2022-05-16 | 11 | $13 | $7 | $10.125 | $10.88 | -6.94% |
| 2022-06-10 | 12 | $13 | $7 | $10.125 | $10.88 | -6.94% |
| 2022-06-14 | 11 | $13 | $7 | $10.125 | $10.88 | -6.94% |
| 2022-07-25 | 11 | $13 | $7 | $10.25 | $10.88 | -5.79% |
| 2022-07-28 | 9 | $13 | $8 | $10.428 | $10.88 | -4.15% |
| 2022-08-04 | 10 | $13 | $8 | $10.375 | $10.88 | -4.64% |
| 2022-09-17 | 10 | $13 | $8 | $10.75 | $10.88 | -1.19% |
| 2022-10-14 | 10 | $13 | $8 | $10.5 | $10.88 | -3.49% |
| 2022-11-03 | 10 | $13 | $8 | $10.5 | $10.88 | -3.49% |
| 2022-11-04 | 12 | $13 | $8 | $10.5 | $10.88 | -3.49% |
| 2022-11-08 | 13 | $13 | $8 | $10.444 | $10.88 | -4.01% |
| 2022-11-14 | 13 | $13 | $8 | $10.3 | $10.88 | -5.33% |
| 2022-11-23 | 13 | $13 | $7 | $10.2 | $10.88 | -6.25% |
| 2022-12-16 | 13 | $13 | $7 | $10.1 | $10.88 | -7.17% |
| 2023-01-09 | 13 | $13 | $7 | $10.3 | $10.88 | -5.33% |
| 2023-01-26 | 13 | $13 | $7 | $10.5 | $10.88 | -3.49% |
| 2023-02-08 | 12 | $13 | $7 | $10.5 | $10.88 | -3.49% |
| 2023-02-09 | 12 | $13 | $8 | $10.6 | $10.88 | -2.57% |
| 2023-02-10 | 12 | $13 | $8 | $10.55 | $10.88 | -3.03% |
| 2023-04-17 | 9 | $14 | $8 | $10.687 | $10.88 | -1.77% |
| 2023-05-01 | 8 | $14 | $8 | $10.687 | $10.88 | -1.77% |
| 2023-05-11 | 8 | $14 | $8 | $10.437 | $10.88 | -4.07% |
| 2023-05-15 | 8 | $14 | $8 | $10.187 | $10.88 | -6.37% |
| 2023-05-21 | 9 | $14 | $8 | $10.187 | $10.88 | -6.37% |
| 2023-05-25 | 10 | $14 | $8 | $10.187 | $10.88 | -6.37% |
| 2023-06-22 | 10 | $14 | $8 | $10.062 | $10.88 | -7.52% |
| 2023-07-13 | 10 | $14 | $8 | $9.833 | $10.88 | -9.62% |
| 2023-07-31 | 9 | $14 | $8 | $10.071 | $10.88 | -7.44% |
| 2023-08-04 | 8 | $14 | $8 | $9.928 | $10.88 | -8.75% |
| 2023-08-07 | 8 | $14 | $8 | $10.285 | $10.88 | -5.47% |
| 2023-09-20 | 8 | $14 | $8 | $10.428 | $10.88 | -4.15% |
| 2023-11-10 | 9 | $14 | $8 | $10.714 | $10.88 | -1.53% |
| 2023-11-27 | 10 | $14 | $8 | $11 | $10.88 | 1.1% |
The Trend in the Analyst Price Target
Over the past 42 months, TEVA's average price target has gone down $0.76.
Over the past 46 weeks, TEVA's average upside potential has been 15.79%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-10 | 12 | 14 | 8 | 10.650 | 10.26 | 3.8% |
| 2023-04-17 | 8 | 14 | 8 | 10.687 | 8.50 | 25.73% |
| 2023-07-31 | 9 | 14 | 8 | 9.812 | 8.40 | 16.81% |
| 2023-10-20 | 8 | 14 | 8 | 10.857 | 8.12 | 33.71% |
| 2023-11-10 | 9 | 14 | 8 | 10.857 | 8.68 | 25.08% |
TEVA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.78 | 3 | 0 | 4 | 2 | 2 | 9 |
The Trend in the Broker Recommendations
Over the past 16 months, TEVA's average broker recommendation rating improved by 0.02.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, TEVA PHARMACEUTICAL INDUSTRIES LTD's average analyst price target is higher than 619.93% of them.
- TEVA has a higher upside potential (average analyst target price relative to current price) than 609.3% of Healthcare stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, TEVA PHARMACEUTICAL INDUSTRIES LTD's number of analysts covering the stock is greater than 3822.83% of them.
- In terms of how TEVA PHARMACEUTICAL INDUSTRIES LTD fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than -2971.26% of that group.
In the Pharmaceutical Products industry, BHC, REGN, and BMY are the three stocks most similar to TEVA PHARMACEUTICAL INDUSTRIES LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is TEVA a Buy, Hold or Sell? See the POWR Ratings now!